Clinical Trial: Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction

U.S., March 4 -- ClinicalTrials.gov registry received information related to the study (NCT06853964) titled 'Retrospective Study of AlloMend Acellular Dermal Matrix (ADM) Allograft and Pre-Pectoral Breast Reconstruction' on Nov. 19, 2024.

Brief Summary: This retrospective, single-site study will provide information regarding the efficiency of AlloMend(R) Acellular Dermal Matrix allograft in Pre-Pectoral Breast Reconstruction surgery following a single or double mastectomy.

Study Start Date: Jan. 27

Study Type: OBSERVATIONAL

Condition: Pre-Pectoral Breast Reconstruction Following Mastectomy

Intervention: OTHER: AlloMend(R) Acellular Dermal Matrix allograft

AlloSource, a non-profit supplier of allografts and one of the nation's leadin...